Member list of California Life Sciences Association

Below you find a list of all members of CLSA in alphabetical order.

Results 821 - 840 out of 950 displayed.
 
Sort direction:
Sort direction:
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41 42  43  44  45  46  47  48 »
Sunomix Therapeutics   
San Diego, USA
Sunomix Therapeutics is a biotechnology company developing novel vaccines and therapeutics using mRNA, nanoparticle, antibody, and protein-based technologies. Its technology portfolio includes mRNA-LPN delivery systems, therapeutic antibodies, antibody-drug conjugate (ADC) nanoparticles, virus-like particles (VLPs), self-assembling protein nanoparticles, and genetic vectors. The company’s programs target infectious diseases and cancer, including experimental vaccines and targeted cancer therapies....
Surrozen, Inc.   
South San Francisco, USA
Surrozen is a biotechnology company, pioneering a new class of Wnt-based therapeutics designed to harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. Built on its proprietary antibody-engineering platform, Surrozen develops multifunctional biologics that selectively activate Wnt signaling in combination with other key disease pathways.
Sutro Biopharma, Inc.   
South San Francisco, USA
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a...
SVB Securities   
San Francisco, USA
SVB Securities is an investment bank, specializing in healthcare. The firm provides services in the areas of mergers, acquisitions, initial public offerings, debt, financing transactions, public equity, publicly marketed follow-on offerings, confidentially marketed follow-on offerings, registered directs, and convertible debt offerings.
Switch Therapeutics   
San Francisco, USA
Switch Therapeutics is a biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science to treat a range of diseases affecting the central nervous system and systemic indications, with significant unmet need. The CASi (Conditionally Activated siRNA) platform, the company’s gene knockdown approach, is based on technology developed by renowned researchers in the field of RNA and drug development. CASi combines advantageous...
Syd Labs, Inc.   
Hopkinton, USA
Syd Labs, Inc. is dedicated to providing products and services for research and development in academy, industry, and government. The company provides comprehensive and competitive services for antibody services, from peptide synthesis, gene synthesis, protein expression, rabbit and mouse polyclonal antibody development, mouse, rat, and rabbit monoclonal antibody development, cloning variable regions of hybridoma cell lines, antibody humanization and engineering, stable cell line generation,...
SyntheX   
San Francisco, USA
SyntheX is the developer of drug discovery platforms intended to use synthetic biology designed to modulate proteins. The company has developed two platforms: ToRPPIDO for discovering protein-protein interaction (PPI) disruptors and ToRNeDO for discovering molecular glue-based functional protein degraders using a pre-specified E3 ligase and neosubstrate, with a pipeline of pre-clinical oncology programs.
Syntr Health Technologies, Inc.   
Irvine, USA
Syntr Health Technologies Inc. is a medical device company, targeting the reduction of diabetic foot amputations in the aging population using the patients own fat.
Sysmex America, Inc.   
Lincolnshire, USA
Sysmex America, Inc. distributes and supports automated in vitro diagnostic hematology, flow cytometry, technology solutions, coagulation and urinalysis analyzers, reagents and information systems for laboratories and healthcare facilities in the Americas.
Tactile Materials Solutions   
San Carlos, USA
Tactile Materials Solutions is a consulting firm providing business strategy, scientific analysis, and litigation support services centered around polymers, chemistry, additive manufacturing, and advanced materials.
Tag.bio   
San Francisco, USA
Tag.bio, enables organizations to securely derive insights using data-as-products in a data mesh architecture. Customers use Tag.bio’s data science platform to discover, share, and unite diverse siloed data sets and execute workloads using no-code/low-code data mesh framework. The data science platform (available in AWS and Azure Marketplaces) combines data sets, smart APIs, statistical and machine learning algorithms into data products (application layer) for users to discover insights via...
Takeda Oncology   
Cambridge, USA
Takeda Oncology, the global oncology business unit of Takeda Pharmaceutical. Takeda Oncology is focused on oncology that combines the agility, ideals and camaraderie of a start-up with the resources of Japan’s largest pharmaceutical company. The company's oncology R&D activities are focused on two therapeutic areas: oncology and inflammation, and are engaged in developing a line of new product candidates for treatments through innate immunity.
Takeda Pharmaceuticals U.S.A., Inc.   
Bannockburn, USA
Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical treatments for metabolic and cardiovascular disease, central nervous system disease, respiratory and immunology, oncology, and general medicine areas. The company offers products for the treatment of type II diabetes, hypertension, insomnia, Alzheimer’s-type dementia, hyperuricemia and gout, peptic ulcer, acid reflux, multiple myeloma, prostate and breast cancer, endometriosis, cancer, malignant lymphoma, and major depressive...
Takeda USA   
Lexington, USA
Takeda is a research-based global company with its main focus on pharmaceuticals. The U.S. hub in Massachusetts is the operational center for the U.S. commercial business unit, global R&D, global oncology, global vaccines, and biologics manufacturing.
Takeda Ventures, Inc.   
Cambridge, USA
Takeda Ventures, Inc. (TVI) is the corporate venture arm of Takeda Pharmaceutical Company Ltd. The company encourages and supports therapeutic innovation in the biopharmaceutical sector and academic centers of excellence through early stage capital investment and the provision of access to the resources of a multinational pharmaceutical company.
Tangible Science   
Redwood City, USA
Tangible Science develops, tangible hydra-PEG, a polymer coating designed to solve the problem of contact lens discomfort. The company improves the contact lens experience for patients, eye care professionals, and contact lens manufacturers.
Target Discovery, Inc.   
Mountain View, USA
Target Discovery, Inc. (TDI) delivers analytical testing services, test support, and packaged testing solutions for the clinical, veterinary, pharmaceutical, food, environmental, agriscience, and consumer product sectors. The company applies advanced technologies and innovative methods to provide cost-effective testing tailored to each client’s needs. TDI focuses on creating rapid, high-performance assays enabled by mass spectrometry selectivity and advanced data-analysis approaches.
TB-Seq, Inc.   
South San Francisco, USA
TB-Seq provides experimental and computational services in cutting-edge RNA sequencing technology, consulting, design, and execution of customized experimental and computational procedures. The company develops applications for experimental and computational procedures for functional (meta)genomics analysis of prokaryotic and eukaryotic organisms and communities based on the ribosome profiling NGS platform technology (RIBO-seq) and on computational analysis of sequencing data.
Tegmine Therapeutics   
San Francisco, USA
Tegmine Therapeutics is a biotechnology that develops antibody-based therapeutics for cancer by targeting tumor-specific glycoproteins. The company has engineered a system to generate revolutionary new antibody-based therapies for cancer which dramatically increase efficacy while reducing toxic side effects. The company's TegMiner™ platform enables the discovery of unique cancer epitopes and allows to develop these life-changing new antibodies for patients with unmet needs.
Teikoku Pharma USA, Inc.   
San Jose, USA
Teikoku Pharma USA, Inc. researches, develops, and manufactures pharmaceutical products based on transdermal drug delivery technologies. The company develops innovative products in the CNS, pain management, and oncology based on its drug delivery platforms.

«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41 42  43  44  45  46  47  48 »

Disclaimer: Any membership totals displayed reflect organizations who have agreed to display their membership information and may not be indicative of CLSA's total member population.

© Biotechgate by Venture Valuation